← Calendar
Readoutin 45d
Pfizer — RSVpreF
Phase 3 primary completion: Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults..
- Date
- Jan 2027
- Type
- Readout
- Indication
- Lower Respiratory Tract Illness
Source ↗Add to calendar
Get told when this date moves
The weekly brief is free. Pro adds reminders 7 days and 1 day before.
More from Pfizer
Apr2027
Readoutin 135d
Pfizer — PG4 Multivalent VaccinePhase 3 primary completion: A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults.
Feb2027
Readoutin 76d
Pfizer — PF-06821497Phase 3 primary completion: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1)..